What happens when lymphoma doesn't respond to DA-R-EPOCH and you're starting epcoritamab?
It sounds like you're facing refractory DLBCL after DA-R-EPOCH didn't work. This is understandably frustrating, but there are still treatment options available.
When lymphoma is refractory (doesn't respond to initial treatment), your Show Full Answer
What happens when lymphoma doesn't respond to DA-R-EPOCH and you're starting epcoritamab?
It sounds like you're facing refractory DLBCL after DA-R-EPOCH didn't work. This is understandably frustrating, but there are still treatment options available.
When lymphoma is refractory (doesn't respond to initial treatment), your care team will recommend different approaches. Epcoritamab is a newer bispecific antibody immunotherapy that can be effective for people whose lymphoma hasn't responded to earlier treatments.
Here are some options others have explored in similar situations:
* Immunotherapy treatments like CAR T-cell therapy (Tecartus, Kymriah) or bispecific antibodies
* Bone marrow transplant
* Clinical trials for newer therapies
* Different chemotherapy combinations
Since your lymphoma didn't achieve remission with DA-R-EPOCH, your doctor is moving to a different mechanism of action with epcoritamab, which may work where chemotherapy didn't.
A MyLymphomaTeam member shared that even after initial treatment failure, second-line and newer therapies can still achieve remission. Keep communicating openly with your oncology team about how you're responding to the new treatment.
November 2, 2025
Join
Your Privacy Choices
